Direkt zum Inhalt
Merck

Fever and leukocytosis related to terconazole vaginal suppository.

Southern medical journal (1994-07-01)
S S Hyder, J E Manjon, N M Gantz
ZUSAMMENFASSUNG

We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More experience with terconazole is needed before it can be considered as safe as other imidazole derivatives that have been available for more than 15 years.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Terconazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Terconazol, VETRANAL®, analytical standard
Terconazol, European Pharmacopoeia (EP) Reference Standard